<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="editorial" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1134989</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2023.1134989</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Regulation of PI3K/Akt signaling pathway: A feasible approach for natural neuroprotective agents to treat various neuron injury-related diseases</article-title>
<alt-title alt-title-type="left-running-head">Chen et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2023.1134989">10.3389/fphar.2023.1134989</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Chen</surname>
<given-names>Yunhui</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1218697/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hsu</surname>
<given-names>Charles</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1453584/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Xiuping</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/781104/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Heng</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1736084/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Peng</surname>
<given-names>Wei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/715217/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>School of Basic Medicine/School of International Education/School of Pharmacy</institution>, <institution>Chengdu University of Traditional Chinese Medicine</institution>, <addr-line>Chengdu</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>College of Medicine, Qatar University</institution>, <addr-line>Doha</addr-line>, <country>Qatar</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Institute of Chinese Medical Sciences, University of Macau</institution>, <addr-line>Macau</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>West China Hospital</institution>, <institution>Sichuan University</institution>, <addr-line>Chengdu</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/439467/overview">Javier Echeverria</ext-link>, University of Santiago, Chile</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/112235/overview">Luca Rastrelli</ext-link>, University of Salerno, Italy</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Yunhui Chen, <email>chenyunhui@cdutcm.edu.cn</email>; Wei Peng, <email>pengwei@cdutcm.edu.cn</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Ethnopharmacology, a section of the journal Frontiers in Pharmacology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>01</day>
<month>02</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1134989</elocation-id>
<history>
<date date-type="received">
<day>31</day>
<month>12</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>01</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Chen, Hsu, Chen, Zhang and Peng.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Chen, Hsu, Chen, Zhang and Peng</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" journal-id="Front. Pharmacol." related-article-type="commentary-article" xlink:href="https://www.frontiersin.org/researchtopic/36326" ext-link-type="uri">Editorial on the Research Topic <article-title>Regulation of PI3K/Akt signaling pathway: A feasible approach for natural neuroprotective agents to treat various neuron injury-related diseases</article-title>
</related-article>
<kwd-group>
<kwd>PI3K/AKT</kwd>
<kwd>natural agents</kwd>
<kwd>neuron injury</kwd>
<kwd>neuroprotective effect</kwd>
<kwd>drug discovery</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Neuron injury is closely associated with the development of various diseases, such as Alzheimer&#x2019;s disease, spinal cord injury, ischemic stroke, and depression. The phosphoinositide-3-kinase (PI3K)/protein kinase B(Akt) signaling pathway is vital for neuron cell growth, development, and survival and can suppress cell apoptosis <italic>via</italic> downregulating proapoptosis proteins. In recent years, a growing body of research has suggested that natural agents are beneficial for preventing or treating neuron injury-related diseases <italic>via</italic> modulating the classical PI3K/Akt signaling pathway. This Research Topic &#x201c;<bold>
<italic>Regulation of PI3K/Akt Signaling Pathway: A Feasible Approach for Natural Neuroprotective Agents to Treat Various Neuron Injury-Related Diseases</italic>
</bold>&#x201d; provided an academic platform to discuss the novel natural neuroprotective agents and how they can be used to treat various neurodegenerative diseases regulating PI3K/Akt Signaling Pathway.</p>
<p>Using network pharmacology and <italic>in vitro</italic> experiments, <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2022.966348/full">Li et al.</ext-link> investigated the neuroprotective effects of Alpiniae oxyphyllae Fructus (AOF) on H2O2 stimulated PC12 cells, and the results suggested that AOF had the potential to treat Alzheimer&#x2019;s disease by suppressing apoptosis induced by oxidative stress <italic>via</italic> the PI3K/Akt pathway. <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2022.990586/full">Liu et al.</ext-link> constructed an <italic>in vitro</italic> neuronal axotomy model to study the therapeutic effects of zinc oxide nanoparticles (ZnO NPs) on spinal cord injury (SCI) and found that ZnO NPs could act as a neuroprotective agent to reduce oxidative stress levels and rescue the neuronal apoptosis <italic>via</italic> the PI3K-Akt signaling pathway, providing new insights for SCI diagnosis and therapeutics. <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2022.1024439/full">Yang et al.</ext-link> reported that Monomethyl lithospermate (MOL), a constituent of Shenxiong Tongmai granule, exerted a protective effect against neural damage caused by ischemic stroke in MCAO rats and OGR/R-induced SHSY-5Y cells, and its mechanism of actions attributed to the suppression of cell apoptosis through activating PI3K/Akt signaling pathway. <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2022.999712/full">Sun et al.</ext-link> adopted integrative approaches of network pharmacology and <italic>in vivo</italic> and <italic>in vitro</italic> experiments to study the antidepressant effect of essential oil from the roots of <italic>Paeonia lactiflora</italic> Pall (EOP) on corticosterone-induced depression and found that EOP might exert anti-apoptotic effects on hippocampal neurons through PI3K/Akt/Nrf2 signaling pathway. <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2022.999962/full">Tang et al.</ext-link> reported the antidepressant effects of the fruits of Zanthoxylum bungeanum Maxim. Essential oil (HEO) on chronic mild unpredictable stimulation (CUMS) mice <italic>via</italic> modulating the HPA axis and activating PI3K/Akt signaling pathway to reduce neuronal apoptosis. In addition, <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2022.1036506/full">Xu et al.</ext-link> presented a review to describe and summarize recent research for sixteen natural terpenoids as neuroprotective agents associated with the PI3K/Akt pathway, providing a stepping stone for further research. And another review by <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2022.1022053/full">Wang et al.</ext-link> illustrated that puerarin, a natural isoflavone extracted from the dried root of Pueraria montana var. Lobata (Willd.) Sanjappa and Predeep, could protect nerve cells and delay the progression of various neurological diseases through the PI3K/Akt signal pathway.</p>
<p>This Research Topic covers the latest scientific research on the regulation of PI3K/Akt signal pathway for natural products to treat different neuron injury-related diseases, including fundamental theory and experiments <italic>in vitro</italic> and <italic>in vivo</italic>. These investigations suggest that targeting PI3K/Akt signal pathway might be feasible for natural neuroprotective agents to manage such diseases as Alzheimer&#x2019;s disease, spinal cord injury, ischemia stroke, and depression. However, other important neuro-injury related diseases have not been reported, such as Parkinson&#x2019;s disease and epilepsy, and more investigations are warranted.</p>
</body>
<back>
<sec id="s1">
<title>Author contributions</title>
<p>All authors listed have made a substantial, direct and intellectual contribution to the work, and approved it for publication.</p>
</sec>
<sec sec-type="COI-statement" id="s2">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s3">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</back>
</article>